A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may predict recurrence of non-functional pancreatic neuroendocrine tumors (pNETs), which do not
U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs.
The confluence of two major health crises—the opioid epidemic and organ shortage—has moved surgeons to consider transplanting organs deemed as less than “perfect” in an effort to expand
Buprenorphine-naloxone (buprenorphine), a highly effective, evidence-based treatment for opioid use disorder (OUD), is difficult to access in states with high rates of death associated with OUD, according to
A Japanese study group clarified that cognitive therapy maintained its effects more than a year after the end of therapy for patients with a social anxiety disorder (SAD)
Drug users on methadone programmes who contract tuberculosis (TB) should receive effective treatment while maintaining the correct level of methadone in their bodies, following a virtual clinical trial
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. The
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors)
A pair of collaborative studies led by Fen-Biao Gao, Ph.D., have identified two potential drug targets for the diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The
Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation’s top health official said Wednesday, responding to a public outcry for government action to
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
